Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure

Nephrology Dialysis Transplantation

Volumn 18, Issue 12, 2003, Pages 2560-2569

  Jolma, Pasi ^a   Kööbi, Peeter ^a   Kalliovalkama, Jarkko ^a,b   Saha, Heikki ^b   Fan, Meng ^a   Jokihaara, Jarkko ^a   Moilanen, Eeva ^a,b   Tikkanen, Ilkka ^c,d   Pörsti, Ilkka ^a,b,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Arterial smooth muscle; Calcium diet; Endothelium; Phosphate binding; Renal failure

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; ACETYLCHOLINE; APAMIN; BUPRENORPHINE; CALCIUM CARBONATE; CALCIUM ION; CEFUROXIME; CHARYBDOTOXIN; DICLOFENAC; LEMAKALIM; METRONIDAZOLE; N(G) NITROARGININE METHYL ESTER; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM ION; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CALCIUM INTAKE; CALCIUM METABOLISM; CONTROLLED STUDY; CUFF; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG MEGADOSE; IN VITRO STUDY; KIDNEY FAILURE; MALE; MESENTERIC ARTERY; MYOGRAPHY; NEPHRECTOMY; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; URINALYSIS; VASODILATATION;

ANIMALS; ARTERIES; BLOOD PRESSURE; CALCIUM CARBONATE; CALCIUM, DIETARY; HYPERPARATHYROIDISM; KIDNEY FAILURE; MALE; NEPHRECTOMY; PHOSPHORUS METABOLISM DISORDERS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0345328216     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg374     Document Type: Article

References (20)

1. Luke RG. Chronic renal failure-a vasculopathic state. N Engl J Med 1998; 339: 841-843
2. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999; 56: 383-392
3. Amann K, Wolf B, Nichols C et al. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997; 29: 770-775
4. Morris STW, McMurray JJV, Spiers A, Jardine AG. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 2001; 60: 1077-1082
5. Rabelink TJ, Koomans HA. Endothelial function and the kidney. Drugs 1997; 53 [Suppl 1]: 11-19
6. Kalliovalkama J, Jolma P, Tolvanen JP et al. Potassium channel-mediated vasorelaxation is impaired in experimental renal failure. Am J Physiol 1999; 277 (4 Pt 2): H1622-H1629
7. Slatopolsky E, Brown A, Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 2001; 37 [1 Suppl 2]: S54-S57
8. Schleiffer R, Xue H, McCarron DA, Bukoski RD. Effect of chronic and subacute parathyroidectomy on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. J Hypertens 1993; 11: 709-716
9. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999; 126: 1049-1055
10. Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. Hypertension 1994; 23: 513-530
11. Ylitalo P, Hepp R, Oster P, Möhring J, Gross F. Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med 1976; 88: 807-816
12. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26
13. 1 receptor antagonism. J Cardiovasc Pharmacol 2002; 40: 478-486
14. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, Carrier GO. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. Am J Physiol 2001; 281: H1524-H1531
15. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277: F157-F175
16. Cupisti A, Rossi M, Placidi S et al. Responses or the skin microcirculation to acethylcholine in patients with essential hypertension and in normotensive patients with chronic renal failure. Nephron 2000; 85: 114-119
17. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
18. 2+-induced relaxation. Am J Physiol 1999; 276: H1035-H1042
19. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M. Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 2000; 27: 855-865
20. Mulvany MJ. Vascular remodelling of resistance vessels: can we define this? Cardiovasc Res 1999; 41: 9-13